HISTOGEN

Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body. The company’s innovative technology platform utilizes cell-conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address underserved, multi-billion US dollar global markets. It was founded in 2007 by Dr. Gail Naughton and is headquartered in San Diego, California.

#People #Financial #Event #Website #More

HISTOGEN

Social Links:

Industry:

Biopharma Biotechnology Medical

Founded:

2007-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.histogen.com

Total Employee:

11+

Status:

Active

Contact:

(858) 200-9520

Total Funding:

87.52 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS PHP GoDaddy DNS AWS Global Accelerator

Current Advisors List

steven-j-mento_image

Steven J. Mento Board of Directors @ Histogen
Board_member

richard-pascoe_image

Richard Pascoe Board of Directors @ Histogen
Board_member

Current Employees Featured

gail-k-naughton_image

Gail K. Naughton
Gail K. Naughton Founder and Scientific Advisor @ Histogen
Founder and Scientific Advisor
2007-01-01

richard-pascoe_image

Richard Pascoe
Richard Pascoe President & Chief Executive Officer @ Histogen
President & Chief Executive Officer

moya-daniels_image

Moya Daniels
Moya Daniels EVP & Head of Regulatory, Quality and Clinical Operations @ Histogen
EVP & Head of Regulatory, Quality and Clinical Operations
2020-10-01

steven-j-mento_image

Steven J. Mento
Steven J. Mento Executive Chairman ,Interim President & CEO @ Histogen
Executive Chairman ,Interim President & CEO

martin-latterich_image

Martin Latterich
Martin Latterich Senior Vice President Of Tech Ops @ Histogen
Senior Vice President Of Tech Ops
2020-08-01

Founder

gail-k-naughton_image

Gail K. Naughton

Stock Details

Company's stock symbol is NASDAQ:HSTO

Acquisitions List

Date	Company	Article	Price
2020-05-27	Conatus Pharmaceuticals	Conatus Pharmaceuticals acquired by Histogen	N/A

Investors List

u-s-department-of-defense_image

Key Employee Changes

Date	New article
2021-11-08	Histogen Announces CEO Transition
2020-10-19	Histogen Appoints Moya Daniels as Executive Vice President and Head of Regulatory, Quality and Clinical Operations

Official Site Inspections

http://www.histogen.com Semrush global rank: 3.78 M Semrush visits lastest month: 3.54 K

Host Informations
Whois Informations

Loading ...